Hyoscyamine Sulfate 0.125 MG Disintegrating Oral Tablet Anaspaz

INDICATIONS AND USAGE ANASPAZ is effective as adjunctive therapy in the treatment of peptic ulcer and irritable bowel syndrome (irritable colon, spastic colon, mucous colitis), acute entercolitis and other functional gastrointestinal disorders. It can also be used to control gastric secretion, visceral spasm and hypermotility in cystitis, pylorospasm and associated abdominal cramps. May be used in functional intestinal disorders to reduce symptoms such as those seen in mild dysenteries and diverticulitis. ANASPAZ is indicated (along with appropriate analgesics) in symptomatic relief of biliary and renal colic and as a drying agent in the relief of symptoms of acute rhinitis.

BF ASCHER AND CO INC

FDA Reported Adverse Reactions
`[1] fatigue` `[2] drug ineffective` `[3] death` `[4] pain` `[5] nausea` `[6] dyspnoea` `[7] off label use` `[8] headache` `[9] diarrhoea` `[10] dizziness`

5 years ago

ROUND YELLOW 0225 0295 A [or] 225 295 A

5 years ago

0225 0295 A [or] 225 295 A ROUND YELLOW

HOW SUPPLIED ANASPAZ (l-

HYOSCYAMINE SULFATE orally disintegrating tablets) 0.125mg is available as a compressed, light yellow, scored tablet, imprinted with the Ascher logo and 225/295 in bottles of 100 tablets (NDC 0225-0295-15) and 500 tablets (NDC 0225-0295-20).

More pills like ROUND 0225 0295 A [or] 225 295 A

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site

Hyoscyamine Sulfate 0.125 MG Disintegrating Oral Tablet Anaspaz

FDA Reported Adverse Reactions [1] fatigue [2] drug ineffective [3] death [4] pain [5] nausea [6] dyspnoea [7] off label use [8] headache [9] diarrhoea [10] dizziness

ROUND YELLOW 0225 0295 A [or] 225 295 A

0225 0295 A [or] 225 295 A ROUND YELLOW

More pills like ROUND 0225 0295 A [or] 225 295 A

FDA Reported Adverse Reactions
`[1] fatigue` `[2] drug ineffective` `[3] death` `[4] pain` `[5] nausea` `[6] dyspnoea` `[7] off label use` `[8] headache` `[9] diarrhoea` `[10] dizziness`